Factors | Transcellular | Paracellular | Net Ca2+ absorption | References |
---|---|---|---|---|
Extrinsic/luminal | ||||
 Ca2+ (long-term low luminal Ca2+ or    low calcium diet) | Increase expression of TRPV5/6, CaBP-D9k, NCX1, PMCA1b, Increase activity of PMCA1b and NCX1 | N/A | ↑ | |
  Ca2+ (prolong exposure to high luminal   Ca2+) | Possibly by increase FGF-23 expression (Ca2+ > 30 mM) and inhibit transcellular transport by unknown mechanism | N/A | ↓ | [84] |
  Iron | N/A | N/A | ↓ | [58] |
  Glucose/galactose (SGLT1 substrates) | Decrease Cav1.3 activity | Increase solvent drag-induced paracellular calcium flow | ↑ | |
  Amino acids | N/A | Increase NHE activity | ↑ | [96] |
Increase nutrient-induced paracellular calcium flow | ||||
  Fructose | Decrease expression of TRPV6 and CaBP-D9k | N/A | ↓ | |
Intrinsic | ||||
  Hormone | ||||
    1,25(OH)2D3 | Increase expression of TRPV5/6, CaBP-D9k, NCX1, PMCA1b | Stimulate nongenomic signaling pathways involving PI3K, PKC, and MEK to enhance calcium transport | ↑ | |
Increase expression of claudin-2, 12 | ||||
    PTH | Increase calcium uptake (Unknown mechanism) | N/A | ↑ | [71] |
    FGF-23 | Decrease 1,25(OH)2D3-enhanced expressions of TRPV5/6, CaBP-D9k | Decrease 1,25(OH)2D3-enhanced paracellular calcium transport and calcium permeability | ↓ | |
 Paracrine | ||||
    FGF-23 | Increase CaSR activity | N/A | ↓ | [84] |
    Stanniocalcin-1 | Decrease expression of TRPV5/6, CaBP-D9k | N/A | ↓ | [107] |
No change in the expression of NCX1, PMCA1b | ||||
Neural (ENS) | ||||
    VIP | N/A | N/A | ↑ (Indirect evidence) | [73] |